Pure Glucagon Antagonists: Biological Activities and cAMP Accumulation Using Phosphodiesterase Inhibitors
- 31 December 1997
- Vol. 18 (5) , 633-641
- https://doi.org/10.1016/s0196-9781(97)00131-9
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Topographical Amino Acid Substitution in Position 10 of Glucagon Leads to Antagonists/Partial Agonists with Greater Binding DifferencesJournal of Medicinal Chemistry, 1996
- [des His1, des Phe6, Glu9]glucagon amide: A newly designed “pure” glucagon antagonistBioorganic & Medicinal Chemistry Letters, 1995
- Synthetic linear and cyclic glucagon antagonistsInternational Journal of Peptide and Protein Research, 1993
- Solid phase peptide synthesis utilizing 9‐fluorenylmethoxycarbonyl amino acidsInternational Journal of Peptide and Protein Research, 1990
- The use of selective inhibitors and computer modelling to evaluate the role of specific high affinity cyclic AMP phosphodiesterases in the hormonal regulation of hepatocyte intracellular cyclic AMP concentrationsCellular Signalling, 1990
- Synthesis of two glucagon antagonists: receptor binding, adenylate cyclase, and effects on blood plasma glucose levelsJournal of Medicinal Chemistry, 1987
- Design and synthesis of glucagon partial agonists and antagonistsBiochemistry, 1986
- An assessment of the ability of insulin-stimulated cyclic AMP phosphodiesterase to decrease hepatocyte intracellular cyclic AMP concentrationsBiochemical Journal, 1984
- Conformation of glucagon in a lipid-water interphase by 1H nuclear magnetic resonanceJournal of Molecular Biology, 1983
- Challenge of hepatocytes by glucagon triggers a rapid modulation of adenylate cyclase activity in isolated membranesBiochemical Journal, 1983